Related Experiment Videos

[Vascular complications in primary hyperlipoproteinemias (HLP) with special reference to changes in the eye fundus]

Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete
|May 15, 1979
PubMed

Insights

Hyperlipoproteinaemia types IIa/IIb and IV/V show distinct prevalence peaks. Associated risks like hypertension, diabetes, and vascular conditions are more severe in types IV/V and III, highlighting the need for targeted interventions.

Area of Science:

  • Cardiology and Metabolic Disorders
  • Lipid Metabolism and Vascular Health

Context:

  • Hyperlipoproteinaemia classification and prevalence.
  • Association of metabolic factors (weight, glucose tolerance) with hyperlipoproteinaemia types.
  • Prevalence of hypertension as a cardiovascular risk factor.

Purpose:

  • To analyze the distribution of hyperlipoproteinaemia types.
  • To investigate the relationship between hyperlipoproteinaemia types and metabolic/vascular risk factors.
  • To assess the impact of co-existing hypertension and diabetes on vascular risk.

Summary:

  • Two main hyperlipoproteinaemia prevalence peaks identified: types IIa/IIb (41%) and types IV/V (55%).
  • Types III-V exhibit significantly higher weight indices and impaired glucose tolerance compared to types IIa/IIb.
  • Hypertension present in 34%; myocardial infarctions highest in types IIb/III, peripheral artery disease (PAD) in type III.
  • Comorbidities like hypertension and diabetes exacerbate vascular risk in hyperlipoproteinaemia.
  • Fundus changes suggestive of hypertensive retinopathy indicate potential hyperlipoproteinaemia even in normotensive individuals.

Impact:

  • Identifies specific hyperlipoproteinaemia types with elevated metabolic and vascular risks.
  • Underscores the compounded vascular risk when hyperlipoproteinaemia coexists with hypertension and diabetes.
  • Suggests funduscopic examination as a potential screening tool for hyperlipoproteinaemia in hypertensive patients.

Related Concept Videos